Doença De Lesão Mínima Flashcards

1
Q

Doença de lesão mínima é mais comum em……

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Achado laboratorial na glomerulonefrite por lesão mínima:

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Quando deve ser feita a Bx renal em crianças com doença de lesão mínima?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Tto da glomerunefrite por lesão mínima:

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

lesao minima

A

the classical cause of the nephrotic syndrome in pediatric populations where it accounts for 90% of cases, accounts for only 10% of cases in adults.

The majority of cases are primary (idiopathic), although an appreciable number may be secondary to another process including; drugs, allergy, malignancy, and infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

lesao minima

causas secundarias

A

non-steroidal anti-inflammatory (NSAIDs), antibiotics, lithium, d-penicillamine and pamidronate.

• Malignancies that may cause MCD are usually hematological, such as Hodgkin or non-Hodgkin lymphoma.

They are usually apparent at the time of the MCD diagnosis.

• A history of allergy may be noted in up to 30% of cases, and relapses may be triggered by an allergic reaction. •

MCD may rarely be associated with infectious etiologies such as syphilis, mycoplasma and tuberculosis.

Infections: Tuberculosis, syphilis, mycoplasma, ehrlichiosis, hepatitis C virus

Neoplasms: Hematologic malignancies, including leukemia, Hodgkin and non-Hodgkin lymphoma

Allergy: Bee and medusa stings, cat fur, fungi, poison ivy, ragweed pollen, house dust

Drugs: NSAIDs, lithium, antibiotics (ampicillin, cephalosporins), immunizations, and gamma interferon

Other glomerular diseases: Associated with IgA nephropathy, SLE, type 1 DM, and HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

lesoes minimas

clinica

“nil disease” or “lipoid nephrosis.

A

: MCD is usually characterized by the abrupt onset of the nephrotic syndrome over a few days to a week,

The nephrotic syndrome itself is characterized by nephrotic range proteinuria (>3.5 g/day), edema, hypoalbuminemia and hyperlipidemia.

This relatively sudden onset is in contrast to the other major causes of nephrotic syndrome – membranous nephropathy and FSGS which are typically more subacute (with the notable exception of the glomerular tip variant of FSGS).

Patients may also have microscopic hematuria and can have a mild decrease in kidney function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

doenca lesoes minimas

FISIOPATOLOGIA

A

nephrotic syndrome characterized by an increased renal membrane permeability and loss of protein (primarily albumin) due to damage to the glomerular filtration barrier (GFB).

The GFB is composed of fenestrated endothelium (inner layer), the glomerular basement membrane (middle layer), and an outer epithelial layer composed of podocytes.

Podocytes are epithelial cells with large cell bodies and long foot processes that run parallel along the outside of glomerular capillaries. The space between foot processes is interspersed by cell-to-cell junctions called slit diaphragms.

Glomerular filtration is both size-specific and charge-specific. The actin cytoskeleton of podocytes provides support to the GBM and regulates flow across the basement membrane depending on hydrostatic pressures, molecular size, and molecular charge.

The apical and luminal membrane of the slit diaphragms and podocytes are coated with a sialoglycoprotein (podocalyxin) which contributes to repels negatively charged molecules such as albumin. The two outer layers of the glomerular basement membrane are composed of heparin sulfate proteoglycans that are also negatively charged and contribute to the charge selectivity of the barrier. Disruption of this barrier leads to the proteinuria seen in nephrotic syndrome.

The pathogenesis of MCD is not exactly known, but it is thought to be multifactorial. Several studies have focused on the integrity and biology of podocytes.

Because the actin cytoskeleton of podocytes maintains the integrity of the podocytes by supporting the cell body and foot processes, regulation of flow across the basement membrane is controlled by a series of interactions.

Some of the proposed theories published include T cell dysfunction/dysregulation that leads to cytokine release and upregulation of proteins, such as CD80 and C-mip that affects the integrity of podocytes, systemic circulating factors that disrupt podocyte function, and B- cell activation (suspected due to the efficacy of anti- CD-20 monoclonal antibodies, such as rituximab).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

lesoes minimas

exame fisico

A

Patients with MCD commonly present with periorbital, scrotum, labia, and/or lower extremity edema. On exam, patients may demonstrate anasarca, pericardial or pleural effusion, ascites, and abdominal pain. An affected individual is an intravascularly volume depleted and maybe oliguric, which can lead to acute kidney injury, a finding most frequently noted in adults.

Children often present with severe infections (sepsis, pneumonia, and peritonitis) due to the depletion of immunoglobulin.

Minimal change disease in adults presents with hematuria, acute kidney injury, and hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

lesoes minimas

quando biopsiar? crianca

A

In children, MCD is primarily a clinical diagnosis, and biopsy is only required in the presence of atypical clinical features:

Age of onset before 1 or after12 years old

Gross hematuria

Low serum C3

Marked Hypertension

Elevated creatinine

Renal failure without hypovolemia

Positive history or serology for secondary causes

Steroid resistance[2]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A successful response to steroids might be anticipated in children how to present with typical clinical findings of MCD and are:

A

Age 1-12 years old

Normotensive

Normal Renal Function

+/- Microscopic hematuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

dlm

A

avaliacao

Nephrotic syndrome is associated with heavy proteinuria, hypoalbuminemia, peripheral edema, hyperlipidemia, and thrombotic disease.

The fluid status in patients with nephrotic syndrome alternates between hypovolemia and hypervolemia.

Hypovolemic patients may be referred to as “underfilled” due to the loss of albumin through proteinuria. Hypoalbuminemia leads to decreased oncotic pressure and fluid sequestration in the interstitial space. Hypoalbuminemia and low oncotic pressure induce reflexes through the juxtaglomerular apparatus to compensate for intravascular fluid losses by increasing sodium absorption and water retention. Patients with MCD are commonly hypovolemic (underfilled).

Hypervolemia (overfill) associated with nephrotic syndrome is due to tubular dysregulation, which increases sodium absorption and water retention. In these patients, hypoalbuminemia and decreased oncotic pressure are not the cause of edema. Therefore, it is important to understand each patient’s volume status before initiating therapy that addresses edema.

In children, MCD is the most common cause of idiopathic nephrotic syndrome. Minimal change disease is the third most common cause of idiopathic nephrotic syndrome in adults after focal segmental glomerular sclerosis and membranous nephropathy. An early kidney biopsy is crucial to making the diagnosis of MCD in adults.[1]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

doença lesao minima

A

dlm no lupus

LES em atividade, e que se apresentam com proteinúria nefrótica, e por vezes sub-nefrótica, sem hematúria e sem hipertensão e que a biópsia renal mostra MO normal e ME com fusão podocitária (padrão de lesões mínimas), ou mesmo glomeruloesclerose segmentar e focal. Em nosso serviço, nos últimos três anos, já temos pelo menos 10 pacientes com LES e esse diagnóstico, confirmado por biópsia renal, com IF negativa e microscopia eletrônica característica de glomerulopatia podocitária.

O diagnóstico diferencial é muito importante, tendo em vista a diferença na resposta terapêutica entre essa entidade e a nefrite lúpica classes IV e V. A podocitopatia associada ao lúpus em geral responde muito bem a corticoterapia e não necessita de outros esquemas de imunossupressão. Sendo assim, é fundamental que os nefrologistas reconheçam essa possibilidade diagnóstica e realizem biópsia dos pacientes lúpicos com síndrome nefrótica, já que não existe um dado clínico que consiga diferenciar com clareza entre as lesões histológicas possíveis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lab para excluir causa secundaria

A

Antinuclear antibodies

Hepatitis B and C serologic tests

Serologic test for syphilis (e.g., rapid plasma reagin)

HIV antibody test

Complement levels (CH50, C3, C4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

lab basico

A

Urinalysis/ Urine microscopy: Dipstick will show 3+/4+ proteinuria. A urine dipstick and urinalysis (UA) are often the initial tests obtained to screen for MCD. In MCD, the urine typically looks frothy secondary to proteinuria, and the microscopy shows oval fat bodies and fatty casts.

Dysmorphic RBCs, acanthocytes, abnormal casts, and proteinuria are findings suggestive of glomerular injury not frequently seen in MCD.

False-positive test results are noted in the presence of mucus, blood, pus, alkalinity, or concentration.A 24-hour urine collection is required to quantitate urinary protein.

Urine collection: A spot protein/creatinine ratio greater than 200 mg/mmol in children and protein/creatinine ratio>300-350mg/mmol in adults is consistent with nephrotic syndrome , as is a 24-hour urine collection that reveals a total protein greater than 3 to 3.5 g/24hour in adults. Microscopic hematuria is present in 10% to 30% of adults.

Complete metabolic panel (CMP): CMP demonstrates a low total protein, low albumin (frequently <2.5 g/dl), and low total calcium (ionized calcium binds to albumin, and albumin is low).

Complete blood count (CBC): CBC will show hemoconcentration and thrombocytosis. This is seen due to the intravascular volume contraction from fluid sequestration into the interstitial space.

Total cholesterol and triglyceride levels: These are increased due to an increase in hepatic lipoprotein synthesis as a result of low oncotic pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

tratamento dlm

A

CORTICOIDE

. Children frequently achieve remission with steroids within 4 weeks vs. adults who achieve remission in two months or more

. The incidence of relapse is high in children and adults.

Children

Initial prednisone therapy is 60 mg/m2(or 2 mg/kg) administered daily for 4-6 weeks (maximum dose, 60 mg/day), or 40 mg/m2/(or 1.5 mg/kg) on alternate days for 2-5 months taper. Reduce the dose by 5 mg/m2 to 10 mg/m2 each week for another four weeks, then stop, with a minimum duration of 12 weeks [14].

Adults

Initial prednisone treatment is 1mg/kg per day or 2 mg/kg/kg every other day (max 80mg/day or 120 mg every other day) for 4-16 weeks. Taper slowly over a course of 6 months after remission

• Prednisolone at a dose of 1 mg/kg (to a maximum of 80 mg) is given daily. This dose is usually continued for eight weeks. For those who have not responded by eight weeks, prednisolone tapering is commenced two weeks after the attainment of remission. • Tapering then occurs slowly, with a total duration of therapy being approximately six months.

17
Q

Pacientes que relapsam

A

Steroid resistance is noted as the persistence of proteinuria in children after 4 weeks of prednisone and after 16 weeks for adults.

Frequent relapses occur, which are defined as two or more relapses in the first six months of presentation or four or more relapses within any 12 months

Relapse is not uncommon, with around 50 to 75% of glucocorticoid responsive patients suffering from a relapse at some point in their disease. Frequent relapses occur in up to 25%. Dependence on steroids to maintain a remission may be seen in up to 30%. Relapses may be triggered by allergic reactions or infections. They typically occur within a year of discontinuation of therapy, but can occur multiple years later.

Steroid dependency is defined as relapses that occur during the tapering phase of steroid therapy or less than two weeks after discontinuing steroids

Relapse nephrosis - > 2+ proteinuria on 3 consecutive days

Prednisolone should be restarted if there is a relapse: 2 mg/kg daily (maximum 60 mg) until in remission for 3 days, then 1.5 mg/kg alternate days for 4 weeks, then stop or taper the dose over 4-8 weeks

18
Q

For frequent relapses/ steroid-dependent (steroid-sparing agents)

A

Cyclophosphamide: the dose of 2 mg/kg/ day for 8 to 12 weeks (should be started after reaching remission with the steroid)- potential gonadal toxicity, alopecia, bone marrow suppression.

Cyclosporine: At a dose of 4 to 5 mg/kg/day, usually for 1-2 years. Levels should be monitored after 1 to 2 weeks. Aim for a trough of 70 to 150. Can cause nephrotoxicity, hirsutism, hypertension, and gingival hyperplasia.

19
Q

If intolerant to the above-mentioned drugs, can give:

A

Mycophenolate mofetil (MMF): Doses of 500 to 1000 mg two times a day for 1 to 2 years. Should be monitored for leukopenia.

Rituximab (chimeric monoclonal antibody): 375 mg/weekly for 1 to 4 doses.[15] Side effects such as fulminant myocarditis, pulmonary fibrosis, fatal Pneumocystis jirovecii infections, ulcerative colitis, and allergic reactions

20
Q

resposta parcial

A

Partial responses are unusual in MCD, and suggest a possible misdiagnosis of FSGS (with the notable exception of the tip lesion of FSGS which remits in a similar fashion to MCD).

Kidney failure is unusual in MCD, and is usually only seen in steroid resistant cases. It is unclear if these cases are truly MCD or FSGS that was missed due to sampling error.

21
Q

Patients who do not respond by 16 weeks are considered to be steroid resistant. In this situation there are a few things that must be considered

A

The initial therapy was inadequate (ie the length of time has not been 16 weeks yet)

  • availability of prednisolone may have been decreased (as may be seen with the concurrent use of aluminium based antacids)
  • The diagnosis is incorrect. The most common lesion in this case is FSGS. Patients who are resistant to therapy are often re-biopsied at this stage. It is not uncommon for those with apparently resistant MCD to actually have FSGS, either due to sampling error in the first sample or perhaps progression of the FSGS over time.
  • There are other rare causes of the nephrotic syndrome such as IgM nephropathy, C1q nephropathy and idiopathic mesangial proliferation that can be mistaken for MCD. The next choice of therapy for glucocorticoid resistant MCD is calcineurin inhibitors. This can also be given as first line in patients unable to tolerate glucocorticoids.
  • Cyclosporine is begun at 4 to 5 mg/kg daily (3 mg/kg in microemulsion preparations) in two divided doses. • Tacrolimus is given 0.05 mg/kg twice daily for at least 26 weeks. This was studied in a small RCT of 50 patients compared to steroids. • It is unclear if patients should be maintained on a small dose of glucocorticoids in addition to the calcineurin inhibitor therapy
  • The length of therapy is unclear. Cyclosporine is often given for 18 months before being tapered to a dose of 2 to 3mg/kg (non-microemulsion preparations). Patients may need to continue on this dose long term to maintain a remission. • In those who have been relapse free after two years it is not unreasonable to withdraw cyclosporine +/- prednisolone (if used together)
22
Q

relapso

A

The majority of patients will relapse at some stage. There is no clear consensus on the best dose of glucocorticoids in this situation. Some would repeat the same initial therapy, whereas others would use the same initial dosing but taper in a more rapid fashion compared to the initial therapy (a typical regime in this case would be 1 mg/kg to a maximum of 80 mg daily for four weeks followed by a taper over one to two months). Some patients have frequent relapses (defined as three or more per year). There are several therapeutic choices. These are typically begun once remission has been induced with glucocorticoids. • Occasional patients will have a sustained remission with low dose glucocorticoid therapy but at the cost of continuous exposure to glucocorticoids. • Cyclophosphamide at a dose of 2 mg/kg daily (orally) for 8 to 12 weeks may be trialed. Cyclophosphamide has a myriad of important side effects that are discussed in other sections of this chapter. • Cyclosporine at similar doses to that used for glucocorticoid resistant disease - 4 to 5 mg/kg daily (3 mg/kg in microemulsion preparations) in two divided doses may be given. These are typically given for around 18 months, after which time a reduction in dose and possible cessation after two years of relapse free therapy may be considered. • Tacrolimus at 0.05 mg/kg twice daily as above. For those requiring cyclophosphamide and cyclosporine it is unclear if low dose prednisolone should be continued during this period.

23
Q

resumo DLM

A

diagnostico=biopsia

tto=corticoide em altas doses por no max 16 sems

diminuir a dose 2 sems apos a remissao ate 24 sems

contraindicacao a corticoide pode usar=cff, inib calcineurina, mmf e baixas doses de corticoide

prognostico excelente

relapsos infrequente = tto com dose menor de corticoide por menos tempo

relapsos frequentes ou dependencia de esteroide= rituximab, cni, mmf